<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=791414221315877&amp;ev=PageView&amp;noscript=1">

2019 Year-End Review and Outlook for 2020

 


Nick Phillips
Posted by Nick Phillips on Dec 30, 2019 10:32:00 AM

2019 Year-End Review and Outlook for 2020

Happy New Year! As we close out the end of this amazing year I wanted to take some time and reflect back on a few important milestones the company was able to accomplish in 2019 and then cover some important items as we start 2020. It was a very productive year and we are set up nicely to have an even more productive year in 2020.

A year in review:

  • Nature-Cide products were introduced and sold to the professional turf grass industry for the first time.
  • Nature-Cide’s international footprint grew with Rentokil in several new countries.
  • Nature-Cide committed to a larger strategic marketing plan with the largest pest control distributors and industry publications.    
  • The company launched its Acquisition Company Roll-Up Strategy and entered into talks with several targets in the pest control service arena. 
  • The company signed a letter of intent and is working to close its first pest control service acquisition.  
  • The company reserved the Nasdaq Symbol “MXRX”.
  • Malibu Brands Pacific Pain Relief Cream was launched. 
  • The company successfully closed its first Regulation A+ offering on StartEngine in June of 2019 capping the round off in the neighborhood of $7 million raised since 2016.
  • The company signed with broker-dealer NMS Capital to partner on its new Regulation A+ capital raise. 
  • The company launched the National Investor Network. 
  • The Marijuana Times helped break the story on contaminated cannabis oil being sold on the black market. 
  • Thermal-Aid products saw growth from Cardinal Health Distribution and direct-to-consumers.
  • Nature-Cide delivered hundreds of samples of products to professionals in 2019 as the word spread around the world.  
  • The company launched its own investment platform for its new Regulation A+ offering.
  • The company surpassed its 2018 revenue in Q4 and reached its 2019 revenue goals. 

It was a challenging but satisfying year for our company. All of the support from our shareholders and partners allowed us to keep this movement going in a positive direction. The brands themselves, especially Nature-Cide, has become globally known as a premier Green Pest Control product line.

2020 is going to require everyone at the company to work harder than they have ever worked. This is the year where we pick up where we left off with direct-to-consumer sales for Thermal-Aid and explore a consumer revenue stream with Nature-Cide for the first time. Our media divisions are positioned to continue to grow especially the National Investor Network. The Equity Crowdfunding Report is already quickly positioning itself as the only media outlet using video to specifically cover the Equity Crowdfunding Markets and new private equity investors are learning about its resources. International pesticide label registration processes for many major countries are underway and we hope for this long process to be completed in 2020 opening the international flood gates for Nature-Cide. Conversations continue with our largest OTC healthcare distributor, Cardinal Health, to increase the footprint of the Thermal-Aid products as well as the introduction of the Malibu Brands Pacific Pain Relief Cream into OTC pharmacies. The company roll-up strategy is scheduled to go into overdrive as our first acquisition wraps up in legal and hopefully it will be announced in early 2020. We have several targets waiting in the wings to see how this first acquisition goes and we are hopeful other like-minded companies are going to want to be a part of this movement. NMS Capital is dedicated to continuing to support our efforts to bring in institutional partners into the mix as we continue our commitment to a listing on a national exchange when the time is appropriate. 

Without the continued support from each and every one of our shareholders we could not have made the progress we did this year. We all look forward to continuing the GREEN movement in these industries that are truly being forced to accept the changes coming. Natural products and services will have a place at the table in 2020 and many years beyond. 

The management team is committed to continuing to keep all of our shareholders apprised and updated on a regular basis, and in 2020 the team will continue to make ourselves available to all of our shareholders anytime. 

I wrapped up the year with an interview with our Chief Media Officer, Nick Philips, on the Equity Crowdfunding Report. It is a long, comprehensive interview. If you are interested in hearing more about 2019 and 2020, we cover many topics in the interview. We are all excited about the show and the buzz it is generating in the equity crowdfunding world. You can watch it by signing up, or logging in if you are already a member of the National Investor Network

Happy New Year!

Sincerely, 

Matthew Mills

President & COO

 

VIDEO INTERVIEW BELOW

Matthew Mills Interview

Topics: Med-X

Comment on this article:

REGULATION A+ Offering is now closed

Recent Posts

Posts by Tag